Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $300.00 | 2 | 54.0% |
| Food and Beverage | $140.11 | 1 | 25.2% |
| Education | $115.17 | 3 | 20.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| COMSORT, Inc | $300.00 | 2 | $0 (2017) |
| Foundation Medicine, Inc. | $140.11 | 1 | $0 (2019) |
| Astellas Pharma US Inc | $99.95 | 1 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $14.50 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $14.50 | 1 | SANOFI-AVENTIS U.S. LLC ($14.50) |
| 2019 | $140.83 | 2 | Foundation Medicine, Inc. ($140.11) |
| 2017 | $399.95 | 3 | COMSORT, Inc ($300.00) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/23/2021 | SANOFI-AVENTIS U.S. LLC | — | Education | In-kind items and services | $14.50 | General |
| 12/16/2019 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $140.11 | General |
| Category: ONCOLOGY | ||||||
| 09/09/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Education | In-kind items and services | $0.72 | General |
| Category: Oncology | ||||||
| 06/08/2017 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.95 | General |
| 03/10/2017 | COMSORT, Inc | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| Category: ONCOLOGY | ||||||
| 03/10/2017 | COMSORT, Inc | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $100.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 402 | 854 | $293,040 | $70,354 |
| 2022 | 8 | 407 | 826 | $270,270 | $78,553 |
| 2021 | 10 | 483 | 1,055 | $292,495 | $112,628 |
| 2020 | 10 | 441 | 1,007 | $195,140 | $96,709 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 107 | 329 | $115,150 | $24,955 | 21.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 53 | 115 | $55,200 | $13,038 | 23.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 57 | 182 | $34,580 | $11,846 | 34.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 47 | 59 | $37,170 | $8,310 | 22.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 35 | 35 | $21,000 | $4,764 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 69 | 88 | $21,560 | $4,351 | 20.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 21 | $5,880 | $2,065 | 35.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 19 | 25 | $2,500 | $1,026 | 41.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 104 | 281 | $98,350 | $22,075 | 22.4% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Facility | 2022 | 30 | 113 | $18,080 | $17,998 | 99.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 58 | 95 | $45,600 | $10,559 | 23.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 49 | 153 | $29,070 | $8,995 | 30.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 40 | 47 | $29,610 | $7,576 | 25.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 52 | 52 | $31,200 | $7,533 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 61 | 68 | $16,660 | $3,301 | 19.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 13 | 17 | $1,700 | $515.40 | 30.3% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Facility | 2021 | 55 | 297 | $47,520 | $47,569 | 100.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 100 | 296 | $97,020 | $23,224 | 23.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 54 | 81 | $36,210 | $9,877 | 27.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 40 | 48 | $26,160 | $8,187 | 31.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 53 | 53 | $28,915 | $7,981 | 27.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 41 | 117 | $20,450 | $7,162 | 35.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 89 | 102 | $24,200 | $5,437 | 22.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 17 | 17 | $7,085 | $1,872 | 26.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 21 | 30 | $2,990 | $979.80 | 32.8% |
About Dr. Salvatore Delprete, MD
Dr. Salvatore Delprete, MD is a Hematology healthcare provider based in Stamford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811082175.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Salvatore Delprete, MD has received a total of $555.28 in payments from pharmaceutical and medical device companies, with $14.50 received in 2021. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($300.00).
As a Medicare-enrolled provider, Delprete has provided services to 1,733 Medicare beneficiaries, totaling 3,742 services with total Medicare billing of $358,244. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Hematology
- Other Specialties Hematology & Oncology, Medical Oncology
- Location Stamford, CT
- Active Since 10/04/2006
- Last Updated 02/25/2008
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1811082175
Products in Payments
- KEYTRUDA (Biological) $300.00
- FOUNDATIONONE (Device) $140.11
- Rubraca (Drug) $0.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.